MERIT MEDICAL SYSTEMS INC Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2025-07-31: Study NCT06807099; Company role Lead sponsor; Phase Observational; Status Recruiting.
- 2025-07-28: Study NCT06422871; Company role Lead sponsor; Phase Observational; Status Recruiting.
- 2025-03-06: Study NCT06587282; Company role Lead sponsor; Phase Not applicable; Status Active not recruiting.
- 2024-08-22: Study NCT06153667; Company role Lead sponsor; Phase Observational; Status Recruiting.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2025-07-31 | NCT06807099 WRAP North America | Lead sponsor | Observational | Recruiting | Venous Stenosis; Venous Occlusion | 250 | 2030-07 |
| 2025-07-28 | NCT06422871 PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis | Lead sponsor | Observational | Recruiting | End Stage Renal Disease; Hemodialysis Access Failure | 100 | 2028-12-28 |
| 2025-03-06 | NCT06587282 PREEMIE: Study for Treatment of PDA in Premature Infants | Lead sponsor | Not applicable | Active not recruiting | Patent Ductus Arteriosus (PDA) | 55 | 2029-03 |
| 2024-08-22 | NCT06153667 Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE) | Lead sponsor | Observational | Recruiting | Uterine Fibroid | 100 | 2026-12 |
| 2024-01-16 | NCT05818150 GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION) | Lead sponsor | Not applicable | Active not recruiting | Knee Osteoarthritis | 264 | 2027-10 |
| 2023-06-01 | NCT06748573 Compression Device to Reduce Pocket Hematoma After Cardiac Implantable Electronic Device Implantation in a High Bleeding Risk Population | Collaborator Lead: Maxime Tijskens | Not applicable | Completed | Pocket Hematoma | 65 | 2024-09-01 |
| 2023-01-16 | NCT05629130 Embolization in Hereditary Coagulopathies | Collaborator Lead: University of Sao Paulo General Hospital | Not applicable | Recruiting | Hemophilia; Embolization; Hemarthrosis; Clotting Factor Deficiency; Synovitis; Arthropathy | 30 | 2029-12-31 |
| 2023-01-16 | NCT03311451 C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study. | Lead sponsor | Not applicable | Active not recruiting | Barrett Esophagus | 62 | 2026-12-18 |
| 2022-11-30 | NCT05307783 EmboCube Gelatin Embolization to Control Bleeding or Hemorrhaging | Lead sponsor | Observational | Completed Results posted | Hemorrhage; Bleeding Hemorrhage | 101 | 2024-04-10 |
| 2022-06-23 | NCT05062291 Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP) | Lead sponsor | Observational | Active not recruiting | Venous Stenosis; Venous Occlusion | 500 | 2027-10-15 |
| 2022-04-01 | NCT04815291 Streamlined Localization Using SCOUT® at Biopsy (STREAMLoc ) | Lead sponsor | Not applicable | Terminated Results posted | Breast Cancer | 93 | 2024-01-15 |
| 2022-02-08 | NCT05050799 US Post-Market Surveillance Study of the Surfacer System | Lead sponsor | Observational | Recruiting | Venous Disease | 30 | 2026-12-15 |
| 2021-08-16 | NCT05006027 Feasibility of PCI Using a 7-Fr Thin-Walled Sheath Via the DRA | Collaborator Lead: Yonsei University | Observational | Completed | Coronary Artery Disease; Distal Radial Artery; Complex Intervention | 100 | 2024-10-15 |
| 2021-03-09 | NCT04540302 The Merit WRAPSODY AV Access Efficacy Study (WAVE) | Lead sponsor | Not applicable | Completed Results posted | Venous Stenosis; Venous Occlusion | 357 | 2025-07-25 |
| 2021-03 | NCT04541576 The Merit WRAPSODY Central Feasibility Study | Lead sponsor | Not applicable | Withdrawn | Venous Stenosis; Venous Occlusion | 0 | 2024-02 |
| 2020-09 | NCT03994185 The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease | Lead sponsor | Not applicable | Withdrawn | Stenosis of Artery; Peripheral Arterial Disease; Iliac Artery Disease; Iliac Artery Occlusion | 0 | 2020-12-31 |
| 2020-03-31 | NCT04218292 Micro Plug Set - Post Market Clinical Follow-up (PMCF) Plan | Collaborator Lead: KA Medical, LLC | Observational | Unknown | Trauma Injury; Bleeding | 40 | 2022-02-28 |
| 2020-03-01 | NCT03960008 Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant | Collaborator Lead: Lahey Clinic | Phase 3 | Terminated Results posted | Hepatocellular Carcinoma; HCC | 9 | 2024-02-28 |
| 2019-01-29 | NCT03644017 The Merit WRAPSODY™ Endovascular Stent Graft | Lead sponsor | Not applicable | Completed Results posted | Venous Stenosis; Venous Occlusion | 46 | 2021-01-20 |
| 2018-09-04 | NCT03554356 Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE) | Collaborator Lead: University of North Carolina, Chapel Hill | Not applicable | Active not recruiting | Barrett Esophagus; Intestinal Metaplasia; Esophageal Dysplasia | 70 | 2027-08 |
| 2018-08-16 | NCT03527589 Embosphere® PROstate Post Market Study | Lead sponsor | Observational | Completed Results posted | Benign Prostatic Hyperplasia; Lower Urinary Tract Symptoms | 499 | 2022-01-22 |
| 2018-07-09 | NCT03414905 Management of Malignant Pleural Effusions Using an Indwelling Tunneled Pleural Catheter and Non-Vacuum Collection System | Collaborator Lead: Washington University School of Medicine | Observational | Completed | Malignant Pleural Effusion | 40 | 2024-02-15 |
| 2017-12-18 | NCT03209050 Evaluation of the Surfacer System Approach to Central Venous Access | Lead sponsor | Not applicable | Completed Results posted | Venous Occlusion | 30 | 2019-06-01 |
| 2017-02-07 | NCT02875899 Surfacer System to Facilitate Access in Venous Occlusions | Lead sponsor | Observational | Completed | Chronic Venous Thrombosis; Venous Thrombosis Upper Extremity; Venous Thrombosis Upper Extremity Superficial Veins | 30 | 2018-10-04 |
| 2016-09-22 | NCT04866290 HepaSphere™ Microspheres Prospective Registry | Lead sponsor | Observational | Completed Results posted | Metastatic Colorectal Cancer | 105 | 2021-06 |
| 2015-10 | NCT02419703 The STAR™ Tumor Ablation Registry | Lead sponsor | Observational | Terminated | Metastatic Lesions in Vertebral Bodies | 65 | 2017-03-20 |
| 2015-01 | NCT02159898 EndoMAXX Endoluminal Valve Technology (EVT) Compared to EndoMAXX | Lead sponsor | Not applicable | Completed Results posted | Malignant Esophageal Strictures | 60 | 2016-12 |
| 2014-12 | NCT02225223 Evaluation of t-RFA and RF-TVA Prior to/Following Radiation Therapy to Treat Painful Metastatic Vertebral Body Tumor(s) | Lead sponsor | Not applicable | Terminated Results posted | Metastatic Lesions in Vertebral Bodies | 35 | 2016-10 |
| 2014-07 | NCT02173522 Phase II Investigation of Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer Patients | Collaborator Lead: Shivank Bhatia | Not applicable | Terminated Results posted | Prostate Cancer | 4 | 2017-06-16 |
| 2013-12 | NCT02164175 Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis | Lead sponsor | Observational | Withdrawn | End Stage Renal Failure on Dialysis | 0 | 2023-12 |
| 2013-10 | NCT02349308 Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter | Lead sponsor | Observational | Completed | Pain; Dialysis Catheter | 10 | 2015-07 |
| 2013-07 | NCT01789840 Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia | Lead sponsor | Not applicable | Terminated Results posted | Benign Prostatic Hyperplasia | 59 | 2017-12 |
| 2011-06 | NCT01387932 HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer | Lead sponsor | Phase 3 | Terminated Results posted | Hepatocellular Carcinoma | 235 | 2021-02 |
| 2011-01 | NCT01343251 HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving Hemodialysis | Lead sponsor | Observational | Completed Results posted | End Stage Renal Disease (ESRD) | 33 | 2013-12 |
| 2008-12 | NCT00889291 HeRO Vascular Access Device Post Market Procedural Survey Protocol | Lead sponsor | Observational | Completed | End Stage Renal Disease | 77 | 2009-01 |
| 2006-03 | NCT00889564 HeRO Vascular Access Device Bacteremia Study | Lead sponsor | Not applicable | Completed | Hemodialysis | 38 | 2007-03 |
| 2004-07 | NCT00890045 Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study | Lead sponsor | Not applicable | Completed Results posted | Renal Failure Chronic Requiring Hemodialysis | 72 | 2008-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |